In vivo evaluation of the virucidal efficacy of Chlorhexidine and Povidone-iodine mouthwashes against salivary SARS-CoV-2

Not Applicable

• Conditions: Antiseptic oral mouthrinse; COVID-19/Transmission during dental treatments.; Prevention; C06.9

• Registration Number: LBCTR2021034768
• Lead Sponsor: ebanese University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-09-30
• Study Start: 2021-03-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 77

Inclusion Criteria

COVID-19 Positive Tested Patients in Rafik Hariri University Hospital, Beirut, Lebanon, presenting mild or moderate symptoms and who (or guardians) give written informed consent.

Exclusion Criteria

1- COVID-19 Positive Tested Patients presenting severe cases.
2- COVID-19 Positive Tested Patients presenting disabilities (Mental retardation-Physical invalidity-Psychological,troubles- Cognitive troubles affecting the capacity of discernation).
3- Patients (or guardians) who decline written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ame: Change in cycle threshold (Ct) values of salivary SARS-CoV-2 (delta Ct) after mouthrinsing.;Timepoints: End of study;Measure: Delta Ct

Secondary Outcome Measures

Name	Time	Method
ame: N/A;Timepoints: N/A;Measure: N/A